United Kingdom Ramipril Shortage
Analysis based on 6 articles · First reported Apr 23, 2026 · Last updated Apr 25, 2026
The shortage of Ramipril in the United Kingdom could lead to increased costs for alternative medications and potential strain on the United Kingdom — National Health Service as patients seek alternatives. This event highlights the fragility of the global supply chain, potentially impacting pharmaceutical companies and healthcare providers.
The United Kingdom is experiencing a serious supply shortage of Ramipril 1.25mg capsules, a widely used high blood pressure medication. The National Pharmacy Association, through its chairman Olivier Picard, has raised concerns about the shortage, noting that pharmacies are unable to order some strengths and costs have soared. The United Kingdom — National Health Service has issued a 'serious shortage protocol' across all four devolved nations, limiting patients to a one-month supply. Ian Maidment of Aston University confirmed the protocol and the availability of alternative ACE inhibitors. The United Kingdom — Department of Health and Social Care acknowledges the limited supply and is working with suppliers to resolve disruptions, while also investing in domestic medicine manufacturing. The situation is attributed to global supply chain fragility and long-term underfunding of pharmacies in the United Kingdom.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard